Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery
Primary Purpose
Pain
Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Bupivacaine
Hydromorphone
Fentanyl
Sponsored by

About this trial
This is an interventional treatment trial for Pain
Eligibility Criteria
Inclusion Criteria:
- Adult subjects aged 18 years or older
- Scheduled for elective posterior lumbar spinal fusion surgery between 1 and 3 levels
Exclusion Criteria:
- Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators.
- Immunocompromised subject
- Coagulopathy
- Severe liver and renal dysfunction
- Preoperative neurological deficits
- The dura damage during surgery
- Inability to follow directions or comprehend the English language.
- Females who are pregnant as determined by positive pregnancy test on or before the day of surgery.
- Prisoners.
- Patient refusal to provide informed consent.
- Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine) or opioid (fentanyl) allergy if patient assigned epidural analgesia.
- Hydromorphone allergy if patient assigned IV PCA
Sites / Locations
- University of Texas Southwestern Medical CenterRecruiting
- University Of Texas Southwestern Medical Center, Zale University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Patient-Controlled Epidural Analgesia
Intravenous patient-controlled analgesia
Arm Description
Bupivacaine and fentanyl infusion via Continuous Lumbar Epidural Analgesia during postoperative 72 hours
Postoperative intravenous patient-controlled analgesia (IV PCA) with Hydromorphone
Outcomes
Primary Outcome Measures
Visual Analog Pain Score (VAS)
Postoperative Visual Analog Pain Score following lumbar fusion surgery
Secondary Outcome Measures
Total opioid consumption
Postoperative opioid consumption
Full Information
NCT ID
NCT03115151
First Posted
April 11, 2017
Last Updated
July 26, 2022
Sponsor
University of Texas Southwestern Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03115151
Brief Title
Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery
Official Title
A Comparison of Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery: A Prospective Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 8, 2017 (Actual)
Primary Completion Date
June 12, 2024 (Anticipated)
Study Completion Date
December 4, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Texas Southwestern Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Postoperative analgesia following spine surgery is difficult to manage. Current treatment modalities rely heavily on opioid analgesics with all of the inherent limitations and side effects. While current best practice focuses on a 'multimodal approach' (i.e. using multiple different drugs and techniques to control pain after surgery), there is no consensus regarding which components of this multimodal therapy provide optimal analgesia. This prospective randomized study will enroll patients undergoing elective Lumbar Spinal Fusion Surgery at Zale Lipshy University Hospital. The primary objective is to determine the comparative efficacy of epidural analgesia, as compared with intravenous (IV) patient-controlled analgesia (PCA), on post-operative analgesia.
Detailed Description
Study Design: Prospective study of 58 subjects undergoing elective Lumbar Spinal Fusion (1-3 levels- posterior approach) at UTSW Zale Lipshy University Hospital with:
Continuous Lumbar Epidural Analgesia (Patient-Controlled Epidural Analgesia- PCEA groups)
Intravenous Patient-Controlled Analgesia (IV PCA)
Study Interventions - The intervention to be evaluated in this study is epidural analgesia using an infusion of 0.0625% bupivacaine plus fentanyl 2mcg/ml. The epidural infusion will be continued until it is appropriate to transition the patient to a regimen of oral pain medications. Duration of epidural catheter will be 72 hours a postoperatively.
For subjects in the IV PCA group, the intervention will include post-operative IV PCA with Hydromorphone.
Epidural catheters will be placed by the spine surgeon under direct visualization intra-operatively prior to closing the surgical incision. Intra-operative epidural catheter placement by the spine surgeon will typically be done at the upper end of the dural exposure/laminectomy.
Epidurals will be assessed for efficacy/function in the recovery room post-operatively by the APS, and then daily on the floor post-operatively (unless contacted by the floor nurse regarding specific concerns).
Visual analog pain scale (VAS) will be used to evaluate degree of pain at 3, 24, 48, and 72 hours after surgery.
Additionally, both the IV PCA and the epidural PCEA groups may be given additional "rescue" pain medications as needed in the recovery room, and these may be continued through the post-operative period on the floor.
Total study duration is approximately 50 days, which starts from operating room admission for spinal fusion surgery to the first follow-up visit after discharge.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
58 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Patient-Controlled Epidural Analgesia
Arm Type
Experimental
Arm Description
Bupivacaine and fentanyl infusion via Continuous Lumbar Epidural Analgesia during postoperative 72 hours
Arm Title
Intravenous patient-controlled analgesia
Arm Type
Sham Comparator
Arm Description
Postoperative intravenous patient-controlled analgesia (IV PCA) with Hydromorphone
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Other Intervention Name(s)
Bupivacaine Hydrochloride
Intervention Description
Bupivacaine (0.0625%) will be combined with fentanyl for postoperative epidural analgesia via a lumbar epidural catheter
Intervention Type
Drug
Intervention Name(s)
Hydromorphone
Other Intervention Name(s)
DILAUDID
Intervention Description
Hydromorphone will be given continuous infusion for intravenous patient controlled analgesia (syringe 25 mg/50 mL).
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Other Intervention Name(s)
Opioid
Intervention Description
Fentanyl (2 mcg/ml) will be given via epidural route together with bupivacaine.
Primary Outcome Measure Information:
Title
Visual Analog Pain Score (VAS)
Description
Postoperative Visual Analog Pain Score following lumbar fusion surgery
Time Frame
Postoperative VAS score at 24 hours
Secondary Outcome Measure Information:
Title
Total opioid consumption
Description
Postoperative opioid consumption
Time Frame
Postoperative the first 24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult subjects aged 18 years or older
Scheduled for elective posterior lumbar spinal fusion surgery between 1 and 3 levels
Exclusion Criteria:
Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators.
Immunocompromised subject
Coagulopathy
Severe liver and renal dysfunction
Preoperative neurological deficits
The dura damage during surgery
Inability to follow directions or comprehend the English language.
Females who are pregnant as determined by positive pregnancy test on or before the day of surgery.
Prisoners.
Patient refusal to provide informed consent.
Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine) or opioid (fentanyl) allergy if patient assigned epidural analgesia.
Hydromorphone allergy if patient assigned IV PCA
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Enas Kandil, MD
Phone
214/648-9374
Email
Enas.Kandil@UTSouthwestern.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Emily Melikman, RN
Phone
214-645-7011
Email
Emily.Melikman@utsouthwestern.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Enas Kandil, MD
Organizational Affiliation
UT Southwestern Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
University of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-9068
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Enas Kandil, MD
Phone
214-648-9374
Email
Enas.Kandil@UTSouthwestern.edu
Facility Name
University Of Texas Southwestern Medical Center, Zale University Hospital
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David McDonagh, MD
Phone
214-648-8083
Email
David.Mcdonagh@UTSouthwestern.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery
We'll reach out to this number within 24 hrs